MD4132C1 - Di(µ-S)-bis{chloro-[phenyl(pyridine-2-yl)methanone-thiosemicarbazonato(1-)]-copper} manifesting the property of inhibiting the proliferation of mammary cancer T-47D cells - Google Patents

Di(µ-S)-bis{chloro-[phenyl(pyridine-2-yl)methanone-thiosemicarbazonato(1-)]-copper} manifesting the property of inhibiting the proliferation of mammary cancer T-47D cells

Info

Publication number
MD4132C1
MD4132C1 MDA20100137A MD20100137A MD4132C1 MD 4132 C1 MD4132 C1 MD 4132C1 MD A20100137 A MDA20100137 A MD A20100137A MD 20100137 A MD20100137 A MD 20100137A MD 4132 C1 MD4132 C1 MD 4132C1
Authority
MD
Moldova
Prior art keywords
copper
mammary cancer
thiosemicarbazonato
manifesting
methanone
Prior art date
Application number
MDA20100137A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD4132B1 (en
Inventor
Aurelian Gulea
Tatiana Straistari
Donald Poirier
Victor Ţapcov
Original Assignee
Государственный Университет Молд0
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Университет Молд0 filed Critical Государственный Университет Молд0
Priority to MDA20100137A priority Critical patent/MD4132C1/en
Publication of MD4132B1 publication Critical patent/MD4132B1/en
Publication of MD4132C1 publication Critical patent/MD4132C1/en

Links

Abstract

The invention relates to chemistry and medicine, namely to a biologically active complex combination of copper with thiosemicarbazone, which can be used in medicine as a cytostatic preparation in the prevention and treatment of mammary cancer.Summary of the invention consists in the synthesis of a new coordinative compound of copper with 2-benzoylpyridine thiosemicarbazone, di(µ-S)-bis{chloro-[phenyl(pyridine-2-yl)methanone-thiosemicarbazonato(1-)]-copper} of formula:manifesting the property of inhibiting the proliferation of mammary cancer T-47D cells.The technical result is to increase the range of coordinative compounds with anticancer activity, which at a concentration of 10-6 mol/L is about 4 times higher than the similar characteristics of the closest analogue from the class of copper thiosemicarbazonates.
MDA20100137A 2010-12-13 2010-12-13 Di(µ-S)-bis{chloro-[phenyl(pyridine-2-yl)methanone-thiosemicarbazonato(1-)]-copper} manifesting the property of inhibiting the proliferation of mammary cancer T-47D cells MD4132C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20100137A MD4132C1 (en) 2010-12-13 2010-12-13 Di(µ-S)-bis{chloro-[phenyl(pyridine-2-yl)methanone-thiosemicarbazonato(1-)]-copper} manifesting the property of inhibiting the proliferation of mammary cancer T-47D cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20100137A MD4132C1 (en) 2010-12-13 2010-12-13 Di(µ-S)-bis{chloro-[phenyl(pyridine-2-yl)methanone-thiosemicarbazonato(1-)]-copper} manifesting the property of inhibiting the proliferation of mammary cancer T-47D cells

Publications (2)

Publication Number Publication Date
MD4132B1 MD4132B1 (en) 2011-10-31
MD4132C1 true MD4132C1 (en) 2012-05-31

Family

ID=45815291

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20100137A MD4132C1 (en) 2010-12-13 2010-12-13 Di(µ-S)-bis{chloro-[phenyl(pyridine-2-yl)methanone-thiosemicarbazonato(1-)]-copper} manifesting the property of inhibiting the proliferation of mammary cancer T-47D cells

Country Status (1)

Country Link
MD (1) MD4132C1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4326C1 (en) * 2013-10-22 2015-09-30 Институт Химии Академии Наук Молдовы N-(D8,13-Bicyclohomofarnesenoylamino)carbazole compound and process for cultivation of Nostoc linckia cyanobacterium with its use
MD4327C1 (en) * 2013-10-22 2015-09-30 Институт Химии Академии Наук Молдовы N-(D8,13-Bicyclohomofarnesenoyl)-3-amino-1,2,4-triazole compound and process for cultivation of Nostoc linckia cyanobacterium with its use

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4520C1 (en) * 2016-12-16 2018-05-31 Государственный Университет Молд0 N-(4-butoxyphenyl)-2-(pyridin-2-ylmethylidene)hydrazinecarbothioamide as T-47D breast cancer cells growth inhibitor

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2695911A (en) * 1951-08-14 1954-11-30 American Home Prod Preparation of copper compounds of thiosemicarbazones
US2723270A (en) * 1950-03-29 1955-11-08 Nepera Chemical Co Inc Thiosemicarbazones of pyridylaldehydes and pyridylketones
EP0135713A2 (en) * 1983-07-28 1985-04-03 The Wellcome Foundation Limited Antiviral combinations
SU1059870A1 (en) * 1981-09-04 1991-04-30 Институт Неорганической Химии Со Ан Ссср Complex compound of copper (11) with thiosepticarbazonic derivative of stable mitroxyl radical of imidazoline, displaying antitumoral activity
US5124351A (en) * 1989-02-27 1992-06-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pharmaceutical compositions for the treatment of cancers susceptible to treatment with the copper complex of S-(methylthio)-DL-homocysteine or the L-enantimorph thereof
WO1993012782A1 (en) * 1991-10-31 1993-07-08 Elford Howard L Method of treating viral diseases
MD195C2 (en) * 1994-12-05 1995-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова The copper complexes with antistaphylococcus properties
WO1998051670A1 (en) * 1997-05-15 1998-11-19 Vion Pharmaceuticals, Inc. Process for the synthesis of ribonucleotide reductase inhibitors 3-ap and 3-amp
WO2001024803A2 (en) * 1999-10-04 2001-04-12 John Carter Pharmaceutical compositions containing copper, salicylic acid and vitamines c
MD1812C2 (en) * 2000-12-29 2002-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Copper complexes as bacteria and fungi inhibitors
US20030016692A1 (en) * 2000-10-26 2003-01-23 Wave7 Optics, Inc. Method and system for processing upstream packets of an optical network
MD2002G2 (en) * 2000-06-02 2003-03-31 Сайентифик Энд Прэдакшэн Ентерпрайз "Еталон", Л.Т.Д. Roller inlet box (variants)
MD2942C2 (en) * 2004-04-27 2006-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Di(µ-O)-bis(3,5-dibromosalicylidene thiosemicarbazonatocopper)
WO2006110119A1 (en) * 2005-04-15 2006-10-19 Victor Pavlovich Kutnyak Antineoplastic preparation
WO2007035489A2 (en) * 2005-09-16 2007-03-29 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating or preventing cancer using pyridine carboxaldehyde pyridine thiosemicarbazone radiosensitizing agents
WO2007035927A2 (en) * 2005-09-23 2007-03-29 Wayne State University Isoflavonoid analogs and their metal conjugates as anti-cancer agents
CN1948304A (en) * 2005-10-12 2007-04-18 桑迪亚医药技术(上海)有限责任公司 Heteraryl ring thiosemicarbazone kind compound and its derivative
CN101260121A (en) * 2007-03-07 2008-09-10 卡南吉医药科技(上海)有限公司 Complex compound of heteroaromatic thiosemicarbazone and transition metal, and application thereof in preparing antineoplastic medicine
AT505367A1 (en) * 2007-05-29 2008-12-15 Faustus Forschung Translationa New ruthenium and osmium-thiosemicarbazonato complex, useful as a drug and for preparing a medicament to treat and prevent cancer, preferably ovarian cancer, breast cancer, lung cancer and colon cancer
MD3655G2 (en) * 2007-09-03 2009-02-28 Государственный Университет Молд0 Inhibitor of human myeloid leukemia on base of bis(2-hydroxy-8-phenyl-tricyclo/7.3.1.0.2,7/-tridecane-13-on-thiosemicarbazonato)copper
MD3771G2 (en) * 2008-04-30 2009-07-31 Государственный Университет Молд0 Inhibitors of 17β-HSD enzyme, stimulator for prostate cancer cell multiplication
MD3995B1 (en) * 2009-05-11 2009-12-31 Universitatea De Stat Din Moldova Use of di(Á-Ophenoxy)-di{[2-(4-aminobenzenesulfamido)-5-ethyl-1,3,4-thiadiazole]-3,5-dibromosalicylidenethiosemicarbazonato(-1)-copper} as inhibitor of mammary cancer T-47D cell proliferation
WO2010006438A1 (en) * 2008-07-17 2010-01-21 Critical Outcome Technologies Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
MD3996C2 (en) * 2009-05-25 2010-07-31 Государственный Университет Молд0 Perchlorates of 5-R-salicylidene-4-phenylthiosemicarbazonato(1-)-aquacopper(II) possessing properties of inhibitors of 17b-HSD enzyme activity (type 1)

Patent Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2723270A (en) * 1950-03-29 1955-11-08 Nepera Chemical Co Inc Thiosemicarbazones of pyridylaldehydes and pyridylketones
US2695911A (en) * 1951-08-14 1954-11-30 American Home Prod Preparation of copper compounds of thiosemicarbazones
SU1059870A1 (en) * 1981-09-04 1991-04-30 Институт Неорганической Химии Со Ан Ссср Complex compound of copper (11) with thiosepticarbazonic derivative of stable mitroxyl radical of imidazoline, displaying antitumoral activity
EP0135713A2 (en) * 1983-07-28 1985-04-03 The Wellcome Foundation Limited Antiviral combinations
US5124351A (en) * 1989-02-27 1992-06-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pharmaceutical compositions for the treatment of cancers susceptible to treatment with the copper complex of S-(methylthio)-DL-homocysteine or the L-enantimorph thereof
WO1993012782A1 (en) * 1991-10-31 1993-07-08 Elford Howard L Method of treating viral diseases
MD195C2 (en) * 1994-12-05 1995-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова The copper complexes with antistaphylococcus properties
WO1998051670A1 (en) * 1997-05-15 1998-11-19 Vion Pharmaceuticals, Inc. Process for the synthesis of ribonucleotide reductase inhibitors 3-ap and 3-amp
WO2001024803A2 (en) * 1999-10-04 2001-04-12 John Carter Pharmaceutical compositions containing copper, salicylic acid and vitamines c
MD2002G2 (en) * 2000-06-02 2003-03-31 Сайентифик Энд Прэдакшэн Ентерпрайз "Еталон", Л.Т.Д. Roller inlet box (variants)
US20030016692A1 (en) * 2000-10-26 2003-01-23 Wave7 Optics, Inc. Method and system for processing upstream packets of an optical network
MD1812C2 (en) * 2000-12-29 2002-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Copper complexes as bacteria and fungi inhibitors
MD2942C2 (en) * 2004-04-27 2006-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Di(µ-O)-bis(3,5-dibromosalicylidene thiosemicarbazonatocopper)
WO2006110119A1 (en) * 2005-04-15 2006-10-19 Victor Pavlovich Kutnyak Antineoplastic preparation
WO2007035489A2 (en) * 2005-09-16 2007-03-29 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating or preventing cancer using pyridine carboxaldehyde pyridine thiosemicarbazone radiosensitizing agents
WO2007035927A2 (en) * 2005-09-23 2007-03-29 Wayne State University Isoflavonoid analogs and their metal conjugates as anti-cancer agents
CN1948304A (en) * 2005-10-12 2007-04-18 桑迪亚医药技术(上海)有限责任公司 Heteraryl ring thiosemicarbazone kind compound and its derivative
CN101260121A (en) * 2007-03-07 2008-09-10 卡南吉医药科技(上海)有限公司 Complex compound of heteroaromatic thiosemicarbazone and transition metal, and application thereof in preparing antineoplastic medicine
AT505367A1 (en) * 2007-05-29 2008-12-15 Faustus Forschung Translationa New ruthenium and osmium-thiosemicarbazonato complex, useful as a drug and for preparing a medicament to treat and prevent cancer, preferably ovarian cancer, breast cancer, lung cancer and colon cancer
MD3655G2 (en) * 2007-09-03 2009-02-28 Государственный Университет Молд0 Inhibitor of human myeloid leukemia on base of bis(2-hydroxy-8-phenyl-tricyclo/7.3.1.0.2,7/-tridecane-13-on-thiosemicarbazonato)copper
MD3771G2 (en) * 2008-04-30 2009-07-31 Государственный Университет Молд0 Inhibitors of 17β-HSD enzyme, stimulator for prostate cancer cell multiplication
WO2010006438A1 (en) * 2008-07-17 2010-01-21 Critical Outcome Technologies Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
MD3995B1 (en) * 2009-05-11 2009-12-31 Universitatea De Stat Din Moldova Use of di(Á-Ophenoxy)-di{[2-(4-aminobenzenesulfamido)-5-ethyl-1,3,4-thiadiazole]-3,5-dibromosalicylidenethiosemicarbazonato(-1)-copper} as inhibitor of mammary cancer T-47D cell proliferation
MD3996C2 (en) * 2009-05-25 2010-07-31 Государственный Университет Молд0 Perchlorates of 5-R-salicylidene-4-phenylthiosemicarbazonato(1-)-aquacopper(II) possessing properties of inhibitors of 17b-HSD enzyme activity (type 1)

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Chumakov Iu. M., Tsapkov V. I., Jeanneau E., Bairac N. N., Bocelli G., Poirier D., Roy J., Gulea A. Crystal structures of copper(II) chloride, copper(II) bromide and copper(II) nitrate complexes with pyridin-2-carbaldehyde thiosemicarbazone. Cryst. Report. 2008, Vol.53, N 5, P. 786-792 *
Douglas X. West et al. Copper(II) complexes of 2-formyl-, 6-methyl-2-formyl- and 2-benzoylpyridine N(4)-(2-methylpyridinyl)-, N(4)-(2-ethylpyridinyl)- and N(4)-methyl(2-ethylpyridinyl)thiosemicarbazones. Transition Met. Chem., 21, 289-295 (1996); (regăsit în Internet la 2011.08.10, url: http://www.springerlink.com/content/g90np851733v87lk/) *
Giorgio Pelosi. Thiosemicarbazone Metal Complexes: from Structure to Activity. The Open Crystallography Journal, 2010, 3, pag. 16-28 *
Prostate cancer (the page was last modified on 08 August 2011), (regăsit în Internet la 2011.08.10, url: http://en.wikipedia.org/wiki/Prostate_cancer ) *
Tarlok S. Lobana et al. Mono- and di-nuclear complexes of thiosemicarbazones with copper(II): Synthesis, spectroscopy and structures. Polyhedron, Vol. 28, Issue 18, December 2009, Pages 3899-3906. doi:10.1016/j.poly.2009.08.028 <http://dx.doi.org/10.1016/j.poly.2009.08.028> (Rezumat regăsit în Internet la 2011.08.11 (abstract+graphical abstract), url: http://www.sciencedirect.com/science/article/pii/S0277538709005890 ) *
Tripathi Laxmi et al. Role of chelates in treatment of cancer. Indian Journal of Cancer, April-June 2007, vol. 44, issue 2, pag. 62-71 (regăsit în Internet la 2011.08.11, url: http://www.bioline.org.br/pdf?cn07011 ) *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4326C1 (en) * 2013-10-22 2015-09-30 Институт Химии Академии Наук Молдовы N-(D8,13-Bicyclohomofarnesenoylamino)carbazole compound and process for cultivation of Nostoc linckia cyanobacterium with its use
MD4327C1 (en) * 2013-10-22 2015-09-30 Институт Химии Академии Наук Молдовы N-(D8,13-Bicyclohomofarnesenoyl)-3-amino-1,2,4-triazole compound and process for cultivation of Nostoc linckia cyanobacterium with its use

Also Published As

Publication number Publication date
MD4132B1 (en) 2011-10-31

Similar Documents

Publication Publication Date Title
SG194447A1 (en) Aryl-or heteroaryl-substituted benzene compounds
EA023222B8 (en) Pyrazolyl quinazoline kinase inhibitors
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
MY146638A (en) Insecticidal aryl isoxazoline derivatives
NZ534830A (en) Compounds with histone deacetylase HDAC inhibiting activity and oral bioavailability useful for treating proliferative diseases
GEP20166438B (en) Imidazopyrrolidinone compounds
MX2012013194A (en) Pyrrolopyrazine derivatives as syk and jak inhibitors.
NZ577916A (en) Cyclopamine analogs
MX360404B (en) Compounds for inhibiting cell proliferation in egfr-driven cancers.
GEP201606532B (en) Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
NZ706739A (en) Substituted benzene compounds
SG182205A1 (en) Organic compounds and their uses
EA201201161A1 (en) Pyrropyrimidines as cdk4 / 6 inhibitors
EA201500652A1 (en) Diftlorometilnikotinovy indanilkarboksamidy
IL210976D0 (en) Organic compounds
MX2013008868A (en) New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors.
MX2015000821A (en) Compounds for targeted immunotherapy.
TW200942552A (en) Combination therapy with c-Met and HER antagonists
WO2013066839A3 (en) Compounds and methods
MX2010007952A (en) Insecticidal arylpyrrolines.
MX2013001363A (en) N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein.
TN2012000249A1 (en) Pyrazine derivatives and their use in the treatment of neurological disorders
EA201391786A1 (en) Halogen-alkyl-1,3-oxazins as bace1 and / or bace2 inhibitors
MX337575B (en) Sulphone compounds for use in the treatment of obesity.
EA201200176A1 (en) Oxazin derivatives and their application for the treatment of neurological disorders

Legal Events

Date Code Title Description
FG4A Patents issued
KA4A Patent lapsed through non-payment of fees (with the right of revalidation under art. 30(3) of patent law)
MM4A Patent definitely lapsed